Orthopedic Manufacturing Firm Will Invest $4.4 Million to Establish New Indiana Facility
09/30/2011
Precision Medical is a contract manufacturer of orthopedic implants and instruments, and serves customers across the United States. It currently employs 75 associates in the state. The firm plans to hire new machinists, CNC programmers and administrative associates next year for the plant.
"Having experienced the work ethic and local support in this area in the past, we are excited to be locating in Noble County and specifically Rome City," said Kurt Kamholz, president and co-owner. The Indiana Economic Development Corporation offered Precision Medical Technologies, Inc. up to $450,000 in performance-based tax credits and up to $35,000 in training grants based on the company's job creation plans. The town of Rome City has granted property tax abatement.
Indiana Secretary of Commerce Mitch Roob noted that the Hoosier state's strong fiscal condition and high-quality work force continue to put it in a favorable position to compete for new investment.
Project Announcements
Poland-Based JGB Brothers Plans Bamberg County, South Carolina, Production Operations
01/23/2026
Electric Research and Manufacturing Cooperative Plans Waddell, Arizona, Transformer Production Operations
01/23/2026
Viking Attachments Expands Morgan City, Louisiana, Manufacturing Operations
01/23/2026
France-Based Reju Plans Rochester, New York, Textile Regeneration Operations
01/23/2026
Heil Trailer International Expands Athens, Tennessee, Manufacturing Operations
01/23/2026
Ampirical Expands Covington, Louisiana, Operations
01/23/2026
Most Read
-
The Workforce Bottleneck in America’s Manufacturing Revival
Q4 2025
-
Data Centers in 2025: When Power Became the Gatekeeper
Q4 2025
-
Speed Built In—The Real Differentiator for 2026 Site Selection Projects
Q1 2026
-
Preparing for the Next USMCA Shake-Up
Q4 2025
-
Tariff Shockwaves Hit the Industrial Sector
Q4 2025
-
Investors Seek Shelter in Food-Focused Real Estate
Q3 2025
-
The New Industrial Revolution in Biotech
Q4 2025